Pfizer Plans to Seek Booster Approval for 16- and 17-Year-Olds

Pfizer and BioNTech plan to apply for FDA authorization this week for a booster COVID-19 vaccine for 16- and 17-year-olds.

Pfizer Plans to Seek Booster Approval for 16- and 17-Year-Olds
vaccine

Pfizer and BioNTech plan to apply for FDA authorization this week for a booster COVID-19 vaccine for 16- and 17-year-olds.